3

MAIN DOCUMENT DESCRIPTION

Company: Oruka Therapeutics, Inc.
Filed: July 30, 2013
Period of Report: July 26, 2013
Accession Number: 0001209191-13-038396

View Document ↗ View on SEC.gov ↗